SCHEMBL14748246

SCHEMBL14748246

N=Cc1cc(F)ccc1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 9/20 0.54
CES2 O00748 2/20 0.43
CES1 P23141 2/20 0.43
CA3 P07451 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
ALDH1A1 P00352 1/20 0.37
ERN1 O75460 1/20 0.35
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905475 0.80 NFE2L2 (0.54) NFE2L2CES2CES1CA3CA6
SCHEMBL1035718 0.80 NFE2L2 (0.54) NFE2L2CES2CES1CA3CA6
SCHEMBL5252638 0.79 NFE2L2 (0.58) NFE2L2CES2CES1CA3CA6
SCHEMBL23457274 0.76 NFE2L2 (0.50) NFE2L2CES2CES1CA3CA6
SCHEMBL21510290 0.76 AR (0.45) NFE2L2CES2CES1CA3CA6
SCHEMBL10297573 0.76 ERN1 (0.38) NFE2L2ERN1
SCHEMBL65723 0.75 ERN1 (0.56) NFE2L2CES2CES1CA3CA6
SCHEMBL491580 0.75 NFE2L2 (0.54) NFE2L2CES2CES1CA3CA6
SCHEMBL16962237 0.75 NFE2L2 (0.54) NFE2L2CES2CES1CA3CA6
SCHEMBL1547513 0.75 NFE2L2 (0.54) NFE2L2CES2CES1CA3CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021211882-A1 METHODS FOR PREPARING TYROSINE RECEPTOR KINASE INHIBITORS PYRAMID BIOSCIENCES, INC. (US) 2021-10-21 WO disclosed
WO-2020224626-A1 COMPOUND USED AS KINASE INHIBITOR AND APPLICATION THEREOF 浙江同源康医药股份有限公司 2020-11-12 WO disclosed
WO-2018106284-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2018-06-14 WO disclosed
EP-2334657-B1 PIPERAZINE D3 AND 5-HT2A RECEPTOR MODULATORS HOFFMANN LA ROCHE (CH) 2013-03-06 EP disclosed